• 
• http://www.nature.com/reviews/drugdisc
• Editor: Peter Kirkpatrick
• Volume 8: 12 issues per year
• ISSN: 1474-1776
• EISSN: 1474-1784
• Impact factor : 23.308*
• Impact ranking: 1/205 in Pharmacology & Pharmacy; 1/138 in Biotechnology & Applied Microbiology*
• Date Established: January 2002
• Published on behalf of:

No. 1 journal in Pharmacology & Pharmacy
No. 1 journal in Biotechnology & Applied Microbiology

Aims and Scope:
Nature Reviews Drug Discovery integrates academia and industry, providing broad, expert coverage of the whole drug discovery and development arena - from disease mechanisms, novel therapeutic approaches and chemistry to clinical trials and regulatory affairs. All reviews are carefully commissioned, written by leaders in the field and subject to rigorous peer-review so that readers receive independent, high-quality and authoritative articles in each issue. Reviews are complemented by news stories that investigate the key issues in drug discovery, timely summaries of significant published papers, market analysis, and updates on the latest advances in fast-moving areas such as new technologies, drug approvals and patent law.

Information is presented at several levels that can be tailored to users' individual needs. Non-specialists will benefit from the glossary and highlighted references, and experts will appreciate the insight provided by top names in their field. Nature Reviews Drug Discovery is a major teaching and reference resource from NPG.

Readership:
People with an interest in the science and business of drug discovery and development, including: biologists, chemists, pharmacologists, toxicologists, informaticians, clinicians, regulatory affairs professionals and pharmaceutical analysts.

Online features and site license access:

• Online archive available back to January 2002.
• A site license provides access to all content published during the supply period. Access is granted to a further rolling four-year archive during the supply period only. Archive content not included in the license agreement is available to purchase.
• Unique online functionality includes figures and tables that can be downloaded as PowerPoint slides, 'Author links', 'At-a-glance summaries' and links to 'Glossaries'.
• Special web focus issues have included a Focus on Antibacterials.
• Indexed in BIOBASE, BIOSIS, CAS, CSA, CAB Abstracts, EMBASE, Scopus, Current Contents, Science Citation Index and Medline (PubMed).

*2007 Journal Citation Report (Thomson Reuters, 2008)